Sotalol
- Generic Name
- Sotalol
- Brand Names
- Betapace, Sorine, Sotylize
- Drug Type
- Small Molecule
- Chemical Formula
- C12H20N2O3S
- CAS Number
- 3930-20-9
- Unique Ingredient Identifier
- A6D97U294I
- Background
Sotalol is a methanesulfonanilide developed in 1960. It was the first of the class III anti arrhythmic drugs. Sotalol was first approved as an oral tablet on 30 October 1992. A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal ...
- Indication
Sotalol is indicated to treat life threatening ventricular arrhytmias and maintain normal sinus rhythm in patients with atrial fibrillation or flutter. There are also oral solutions and intravenous injections indicated for patients requiring sotalol, but for whom a tablet would not be appropriate.
- Associated Conditions
- Sinus Rhythm, Life-threatening ventricular arrhythmias
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.